MedPath
NMPA Approval

Vigabatrin Powder for Oral Solution

国药准字H20249622

December 1, 2024

Drug Information

氨己烯酸口服溶液用散

散剂

500mg

化学药品

December 1, 2024

Company Information

Applicant Company

硚口区硚口路160号1幢23层1-6号

Manufacturing Company

湖北省武汉市东西湖区金银湖生态园环湖中路11号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氨己烯酸口服溶液用散 - NMPA 批准文号 | MedPath